Charles Schwab’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Sell |
310,580
-4,436
| -1% | -$23.8K | ﹤0.01% | 2726 |
|
|
2025
Q1 | $1.68M | Sell |
315,016
-7,560
| -2% | -$40.4K | ﹤0.01% | 2668 |
|
|
2024
Q4 | $2.88M | Buy |
322,576
+8,311
| +3% | +$74.3K | ﹤0.01% | 2560 |
|
|
2024
Q3 | $3.46M | Buy |
314,265
+189,727
| +152% | +$2.09M | ﹤0.01% | 2538 |
|
|
2024
Q2 | $1.13M | Sell |
124,538
-6,531
| -5% | -$59.4K | ﹤0.01% | 2886 |
|
|
2024
Q1 | $1.84M | Buy |
131,069
+44,287
| +51% | +$623K | ﹤0.01% | 2617 |
|
|
2023
Q4 | $666K | Buy |
86,782
+18,558
| +27% | +$143K | ﹤0.01% | 2969 |
|
|
2023
Q3 | $509K | Hold |
68,224
| – | – | ﹤0.01% | 3031 |
|
|
2023
Q2 | $568K | Buy |
+68,224
| New | +$568K | ﹤0.01% | 2990 |
|
|
2021
Q2 | – | Sell |
-7,602
| Closed | -$132K | – | 3415 |
|
|
2021
Q1 | $132K | Sell |
7,602
-1,206
| -14% | -$20.9K | ﹤0.01% | 3357 |
|
|
2020
Q4 | $114K | Hold |
8,808
| – | – | ﹤0.01% | 3312 |
|
|
2020
Q3 | $328K | Hold |
8,808
| – | – | ﹤0.01% | 3002 |
|
|
2020
Q2 | $340K | Buy |
+8,808
| New | +$340K | ﹤0.01% | 2983 |
|